, Fifth Version (DSM-5)—a reference text industry experts use to diagnose compound use disorders along with other psychiatric disorders—incorporates diagnoses of phencyclidine (PCP) use disorder and “other hallucinogen use disorder” but will not contain material use disorder diagnoses connected with other distinct copyright and dissociative